- Home
- / Mochida Pharmaceutical
Mochida Pharmaceutical
Stock Price
¥3.4 K
2024-10-29
Market Capitalization
¥121.1 B
2024-10-28
Revenue
¥105.2 B
FY, 2025
Mochida Pharmaceutical Summary
Company Summary
- Overview
- Mochida Pharmaceutical (持田製薬株式) is a company providing pharmaceuticals. It offers healthcare products to treat ulcerative colitis, pulmonary arterial hypertension, acute pancreatitis, chronic constipation, etc.
- Type
- Public
- Status
- Active
- Founded
- 1913
- HQ
- Shinjuku City, JP | view all locations
- Website
- http://www.mochida.co.jp/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Shinjuku City, Tokyo HQ
Japan
Mochida Pharmaceutical Financials
Summary Financials
- Revenue (Q3, 2026)
- ¥87.5B
- Gross profit (Q3, 2026)
- ¥44.0B
- Net income (Q3, 2026)
- ¥6.3B
- Cash (Q3, 2026)
- ¥38.5B
- EBIT (Q3, 2026)
- ¥8.2B
- Enterprise value
- $92.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026